Mannan chain length controls lipoglycans signaling via and binding to TLR2.
about
A tethering mechanism for length control in a processive carbohydrate polymerizationThe structure of the first representative of Pfam family PF06475 reveals a new fold with possible involvement in glycolipid metabolismMycobacterium tuberculosis lipoprotein LprG (Rv1411c) binds triacylated glycolipid agonists of Toll-like receptor 2Src homology 3-interacting domain of Rv1917c of Mycobacterium tuberculosis induces selective maturation of human dendritic cells by regulating PI3K-MAPK-NF-kappaB signaling and drives Th2 immune responsesA murine DC-SIGN homologue contributes to early host defense against Mycobacterium tuberculosisA truncated lipoglycan from mycobacteria with altered immunological properties.Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host.Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineagesLipoglycans contribute to innate immune detection of mycobacteriaRegulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptorsDivergent effects of mycobacterial cell wall glycolipids on maturation and function of human monocyte-derived dendritic cells.The cell envelope glycoconjugates of Mycobacterium tuberculosisOrganelle membrane proteomics reveals differential influence of mycobacterial lipoglycans on macrophage phagosome maturation and autophagosome accumulation.Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2.Manipulation of the endocytic pathway and phagocyte functions by Mycobacterium tuberculosis lipoarabinomannan.Gram-positive bacterial lipoglycans based on a glycosylated diacylglycerol lipid anchor are microbe-associated molecular patterns recognized by TLR2Mycobacterial phosphatidylinositol mannoside 6 (PIM6) up-regulates TCR-triggered HIV-1 replication in CD4+ T cells.Lipoarabinomannan biosynthesis in Corynebacterineae: the interplay of two α(1→2)-mannopyranosyltransferases MptC and MptD in mannan branching.Animal models of tuberculosis: zebrafishMycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b.Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interactionDifferential arabinan capping of lipoarabinomannan modulates innate immune responses and impacts T helper cell differentiationDisruption of Mycobacterial AftB Results in Complete Loss of Terminal β(1 → 2) Arabinofuranose Residues of Lipoarabinomannan.Mycobacterial Dormancy Systems and Host Responses in Tuberculosis.Mannan core branching of lipo(arabino)mannan is required for mycobacterial virulence in the context of innate immunityOutcome of Mycobacterium tuberculosis and Toll-like receptor interaction: immune response or immune evasion?Mycobacterial phenolic glycolipids with a simplified lipid aglycone modulate cytokine levels through Toll-like receptor 2.Mycobacterium tuberculosis promotes HIV trans-infection and suppresses major histocompatibility complex class II antigen processing by dendritic cells.A network of hydrogen bonds on the surface of TLR2 controls ligand positioning and cell signaling.Characterization of a Mycobacterium avium subsp. avium operon associated with virulence and drug detoxification.Commensal Fungi Recapitulate the Protective Benefits of Intestinal Bacteria.Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids.
P2860
Q24644915-F452E469-9616-44B6-A23F-1FD6B9914E68Q27644193-D1E55CB0-73F9-454A-AB7E-55C67E3BB96FQ27663955-B5A656A6-58A6-40F6-BEB1-5C66153C1EAFQ28487315-E6E1E680-3A7D-40E8-BE18-4743DC12E2B4Q28512458-C7F0E399-C54F-45C2-B005-7F7C545B9E6DQ33664341-8630FFAB-619F-4CB3-8F36-A3BFA0629000Q33794104-C355CEB6-C3FD-4DE4-9883-06A68959A76DQ33847927-08245E46-0CA6-4C3B-8A3B-2B8E64FAADBBQ34099267-A0F57B1F-6A01-4420-AA4F-B0F042B5C570Q34104329-52EBB519-829F-4ECB-8BD8-FFA3F4966F6FQ34374228-BD1DACA6-398E-47E6-A327-025E22971797Q34423962-5E21465E-FF5F-4AE0-B18E-EB78510E0100Q34477748-788FA8CB-A90B-4341-9184-6048F301A1B6Q34529474-84703D82-DEF1-47AB-8B9C-72EB048FC78EQ34913897-C7D2FD46-3518-4A36-9BBC-1A6C0FC49C75Q35054065-B44E706A-9CFD-456D-902B-DF6E1A79014EQ35055182-95F616B3-7E67-447A-B6DE-ABD7AF513EEDQ35069666-099D2F4C-C2CC-4C45-B46E-81BADDE3A3DAQ35164289-193E5BEA-8654-473C-B23C-70914806018BQ35408747-2870CBDB-CC68-4F66-B38C-A61D64E6E21AQ35589680-34CEC4AC-5DF6-4355-8754-868C3EDAB2A9Q36492770-CEF44200-F444-4B17-94BA-DAB99F8156F8Q37602141-5FB47CA3-BB69-4BC3-A098-A307DB0D5943Q37642050-182720FA-D19F-4A9B-A0F7-F8EAC514A8B3Q37658428-6A7E7D01-9574-489C-9219-0ECB23FDF2E9Q38225182-810D979A-9946-48F5-B410-1FB6339BC769Q39081826-85A02469-7979-4E41-B0EA-DB0A8FDB2B93Q39686472-BBC75C7E-2B8D-4705-AFFD-70F33D49C81DQ39763713-929D83B4-6E9F-4A8A-B4E4-82184789B1B4Q40635856-E5308B69-7737-4F07-94E9-8578E69BDDFCQ46254511-40F5F984-5A65-42BC-BB6C-DE44E109A6F4Q48251113-8A98644A-71DC-488C-93C5-A3C89B605C24
P2860
Mannan chain length controls lipoglycans signaling via and binding to TLR2.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Mannan chain length controls lipoglycans signaling via and binding to TLR2.
@en
Mannan chain length controls lipoglycans signaling via and binding to TLR2.
@nl
type
label
Mannan chain length controls lipoglycans signaling via and binding to TLR2.
@en
Mannan chain length controls lipoglycans signaling via and binding to TLR2.
@nl
prefLabel
Mannan chain length controls lipoglycans signaling via and binding to TLR2.
@en
Mannan chain length controls lipoglycans signaling via and binding to TLR2.
@nl
P2093
P50
P1476
Mannan chain length controls lipoglycans signaling via and binding to TLR2.
@en
P2093
Aurélie Ray
Gurdyal S Besra
Gérard Tiraby
Iain Sutcliffe
Patricia Constant
Thierry Vasselon
P304
P356
10.4049/JIMMUNOL.180.10.6696
P407
P577
2008-05-01T00:00:00Z